Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection

David H Dockrell1, Helen M Marriott, Lynne R Prince

  • 1Division of Genomic Medicine, University of Sheffield School of Medicine and Biomedical Sciences, Sheffield, United Kingdom. d.h.dockrell@sheffield.ac.uk

Insights

Alveolar macrophages (AM) are crucial for clearing lung infections. Inhibiting AM apoptosis during pneumococcal infection increases bacterial growth, highlighting AM

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Microbiology

Background:

  • Alveolar macrophages (AM) are critical immune cells in the lungs.
  • Their precise role in host defense against pulmonary infections is not fully understood, particularly in resolving infection models.
  • Existing in vivo models often focus on severe infections, potentially obscuring the function of AM in less acute scenarios.

Purpose of the Study:

  • To investigate the function of alveolar macrophages (AM) in a novel model of resolving pulmonary infection.
  • To elucidate the role of AM apoptosis in host defense against Streptococcus pneumoniae.

Main Methods:

  • Developed a low-dose intratracheal pneumococcal infection model in C57BL/6 mice to simulate resolving infection.
  • Utilized AM depletion strategies to assess their impact on bacterial clearance.
  • Investigated the effect of caspase inhibition on AM apoptosis and bacterial dissemination (bacteremia).

Main Results:

  • Low-dose pneumococcal infection in mice resulted in bacterial clearance without severe pneumonia, establishing a resolving infection model.
  • Depletion of AM significantly enhanced bacterial outgrowth in the lungs.
  • Infection led to increased apoptosis of AM, and caspase inhibition reduced this apoptosis while increasing bacteremia.

Conclusions:

  • Alveolar macrophages play a significant role in clearing bacteria during subclinical pulmonary infections.
  • AM apoptosis is an integral component of the host's innate immune defense against pneumococcal lung infections.
  • Targeting AM apoptosis may represent a therapeutic strategy for enhancing pulmonary defense.